The global dermal fillers market is traversing a path from the growth phase to maturity as companies are focussing on developing variants of products currently available in the global dermal fillers market. According to this new report titled “Dermal Fillers Market: Global Industry Analysis (2012–2016) and Opportunity Assessment (2017–2027)”that tracks the performance of the global dermal fillers market for a period of 10 years, the United States is a highly mature market with wide scale adoption of dermal fillers. This new report published by Future Market Insights discusses the high pricing competition and discounting practices between companies as well as physician practices that inflate margins and tend to hamper global adoption of the dermal filler procedure by patients.
Global Dermal Fillers Market: Trends
- Increasing preference for non-surgical procedures
- Celebrity endorsements and direct consumer marketing
- Increasing popularity of anti-ageing treatments and active interest for dermal rejuvenation
- Advanced process technology for newer formulation of fillers and several combination products in the pipeline
- Rising expenditure on cosmetics and aesthetics procedures
- Increasing training programs for aesthetic practitioners and increasing foreign investments
- Use of three dimensional imaging techniques for assessment and emergence of online sales channels
- Beauty service demand patterns and micro-injectable dermal fillers that results in better looking skin
Global Dermal Fillers Market: Forecast by Product Type
On the basis of product type, the global dermal fillers market is segmented into absorbable and non-absorbable. The non-absorbable product type segment – with a market attractiveness index of 0.01 – is not expected to make a major impact over the forecast period. For example PMMA-based fillers are not as preferred, given their limited bio-compatibility.
Global Dermal Fillers Market: Forecast by Ingredients
The ingredient segment comprises hyaluronic acid, poly-L-Lactic acid, calcium hydroxylapatite, polymethyl methacrylate and collagen. Several manufacturers are developing newer, long-lasting formulations of hyaluronic acid-based fillers that are expected to lead to rapid adoption over the projected period. Collagen is expected to remain the least attractive ingredient in the global market in revenue terms with an attractiveness index of 0.02 over the projected period.
Global Dermal Fillers Market: Forecast by Application
The application segment includes aesthetic restoration, dentistry and reconstructive surgery. In 2017, the aesthetic restoration segment is projected to be valued at US$ 2,693.9 Mn and is estimated to grow significantly to reach a market value of US$ 3,646.1 Mn in the year 2027. This segment is likely to grow at a CAGR of 3.1% during the study period.
Global Dermal Fillers Market: Forecast by Distribution Channel
On the basis of distribution channel, the global dermal fillers market is segmented into retail pharmacies and drug stores, clinics and hospital pharmacies, and online pharmacies. Online pharmacies are expected to be the fastest growing distribution channel segment for dermal fillers over the forecast period given the rapid adoption rate.
Global Dermal Fillers Market: Forecast by Region
North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA are the seven regions included in this report. The dermal fillers market in North America is expected to be the most lucrative, with a market attractiveness index of 2.5. Major players in the dermal fillers market, including Allergan and Galderma, are focussing on improving the sale of hyaluronicacid-based fillers in North America. Companies are trying to exploit full market potential and get maximum returns on R&D till patents for their products are valid. The market in APEJ is expected to be the fastest growing among all regions.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5699
Global Dermal Fillers Market: Key Players
Some of the key players operating in the global market for dermal fillers are GaldermaPharmaS.A., Sinclair Pharma plc., Zimmer Biomet Holdings, Allergan plc., Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, SunevaMedical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Adoderm GmbH, Laboratoires Vivacy SAS, Fidia Pharma USA Inc.